SecSonar.com

Surrozen, Inc. (SRZN)

Surrozen, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Surrozen, Inc. (SRZN) is a Biotechnology company based in US with a market capitalization of $184.8M. Free cash flow was negative at -$30.4M. This page tracks SRZN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 40 employees · IPO Jan 11, 2021

Valuation

Valuation & price

$28.15 · as of May 17, 2026 · -17.5% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$34.13$21.23$8.32Jul 25Dec 25Jul 26Jul 7, 25$8.35Jul 9, 25$8.32Jul 11, 25$8.71Jul 15, 25$8.41Jul 17, 25$8.50Jul 21, 25$8.70Jul 23, 25$8.68Jul 25, 25$8.95Jul 29, 25$9.25Jul 31, 25$10.00Aug 4, 25$10.94Aug 6, 25$10.36Aug 11, 25$9.99Aug 13, 25$10.06Aug 15, 25$11.14Aug 19, 25$11.15Aug 21, 25$11.35Aug 25, 25$11.50Aug 27, 25$11.40Aug 29, 25$12.19Sep 3, 25$12.54Sep 5, 25$12.20Sep 9, 25$11.71Sep 11, 25$11.41Sep 16, 25$11.56Sep 18, 25$11.98Sep 22, 25$12.20Sep 24, 25$11.75Sep 26, 25$11.56Sep 30, 25$12.89Oct 2, 25$13.77Oct 6, 25$13.84Oct 8, 25$14.04Oct 10, 25$13.77Oct 14, 25$13.64Oct 16, 25$13.60Oct 21, 25$13.85Oct 23, 25$13.71Oct 27, 25$13.93Oct 29, 25$13.59Oct 31, 25$14.00Nov 4, 25$12.59Nov 6, 25$12.50Nov 10, 25$11.80Nov 12, 25$12.94Nov 14, 25$12.98Nov 18, 25$12.95Nov 20, 25$13.74Nov 25, 25$16.01Nov 28, 25$16.58Dec 2, 25$15.54Dec 4, 25$18.23Dec 8, 25$20.47Dec 10, 25$23.95Dec 12, 25$24.59Dec 16, 25$22.36Dec 18, 25$21.49Dec 22, 25$23.00Dec 24, 25$22.90Dec 29, 25$21.77Jan 2, 26$21.55Jan 6, 26$19.67Jan 8, 26$19.06Jan 12, 26$18.00Jan 14, 26$20.00Jan 16, 26$20.00Jan 21, 26$19.17Jan 23, 26$19.60Jan 27, 26$23.03Jan 29, 26$22.08Feb 2, 26$22.10Feb 4, 26$23.65Feb 9, 26$22.14Feb 11, 26$24.60Feb 13, 26$24.48Feb 18, 26$25.09Feb 20, 26$26.59Feb 24, 26$27.00Feb 26, 26$25.75Mar 2, 26$28.60Mar 4, 26$28.54Mar 6, 26$27.04Mar 10, 26$27.74Mar 12, 26$25.90Mar 17, 26$25.60Mar 19, 26$26.63Mar 23, 26$25.24Mar 25, 26$26.14Mar 27, 26$28.90Mar 31, 26$29.13Apr 2, 26$27.87Apr 7, 26$25.77Apr 9, 26$27.45Apr 13, 26$29.86Apr 15, 26$32.02Apr 17, 26$31.56Apr 22, 26$33.03Apr 24, 26$28.14Apr 28, 26$30.98Apr 30, 26$33.40May 4, 26$32.07May 6, 26$34.13May 8, 26$28.96May 12, 26$30.66May 14, 26$29.87May 18, 26$27.44May 20, 26$27.05May 22, 26$26.37May 28, 26$26.16Jun 1, 26$24.71Jun 3, 26$24.57Jun 5, 26$21.52Jun 9, 26$21.50Jun 11, 26$23.37Jun 15, 26$23.14Jun 17, 26$24.04Jun 22, 26$23.66Jun 24, 26$24.75Jun 26, 26$25.22Jul 2, 26$24.92
$8.2952-week range$34.13
Loading valuation history…

Fundamentals

Key fundamentals

$184.8M

Market cap

—

Revenue growth (YoY)

84.6%

Gross margin

-$30.4M

Free cash flow (USD)

-$82.6M

Net debt

Net cash position

155.0%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$12.5MFY 2023$0.00FY 2024$10.7MFY 2025$3.5M
$0$3.5M

Free cash flow by year

2019 → 2025

FY 2019$-22.6MFY 2020$-30.0MFY 2021$-50.1MFY 2022$-44.9MFY 2023$-40.8MFY 2024$-17.7MFY 2025$-30.4M
-$22.6M-$30.4M

Gross margin by year

2022 → 2025

FY 202273.8%FY 2024100.0%FY 202584.6%
73.8%84.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsMay 14, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing

Questions

Frequently asked questions

What is Surrozen, Inc.'s market cap?

Surrozen, Inc. (SRZN) has a market capitalization of $184.8M.

What is SRZN's P/E ratio?

A meaningful P/E ratio is not available for SRZN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying SRZN stock?

SEC Form 4 filings show no open-market insider buys at Surrozen, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

IPHA

Innate Pharma S.A.

$182.2M

AVTX

Avalo Therapeutics, Inc.

$179.1M

IFRX

InflaRx N.V.

$175.9M

ARTV

Artiva Biotherapeutics, Inc.

$193.8M

TNXP

Tonix Pharmaceuticals Holding Corp.

$198M

CHRS

Coherus Oncology, Inc.

$198.7M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.